FDNA, Inc. Newsroom

FDNA, Inc. develops AI next-generation phenotyping technology that helps clinicians, labs, researchers, and families address developmental, rare, and genetic disorders earlier. Used in 10,000+ medical centers across 130+ countries and cited in 150+ peer-reviewed publications. Face2Gene, its clinician-facing tool, supports syndrome prioritization and gene-prioritization context for qualified healthcare professionals - informational and non-diagnostic. Family Health Checker helps parents organize concerns and prepare for a clinician visit (US) - also non-diagnostic. Learn more at fdna.com.